期刊文献+

乳腺癌术前MRI特征对保乳术中切缘阳性的预测价值分析 被引量:7

The value of preoperative MRI features of breast cancer in predicting the positive margins during breast-conserving surgery
下载PDF
导出
摘要 目的:研究乳腺癌术前MRI特征对保乳术中肿瘤切缘阳性的预测诊断价值。方法:回顾分析本院2017年9月-2019年6月有完整术前MRI资料且首次手术为保乳术的176例浸润性乳腺癌进行研究,根据术中病理的切缘情况分为切缘阳性组(56例)和切缘阴性组(120例)。分析每个病例的术前MRI图像,提取包括乳腺纤维腺体类型,同侧和对侧背景实质强化类型,病灶类型,肿块形态和边缘特征,非肿块样强化病灶分布特征,病灶最长径,是否为多中心病灶等MRI特征以及基本的临床、病理特征。通过单因素比较两组间各种MRI特征和基本临床病理特征的差异,再将单因素分析有统计学意义的MRI特征进行多因素Logistic回归分析,采用受试者操作特征(ROC)曲线评价回归模型对保乳术中切缘阳性的预测诊断价值。结果:本组研究的保乳术中切缘阳性率为31.8%(56/176例)。单因素分析结果显示,在MRI特征中,较大的病灶最长径(t=3.162,P=0.002),存在多中心病灶(F=17.853,P=0.000),非肿块样强化的病灶类型(F=11.019,P=0.001)是保乳术中切缘阳性的预测特征;在基本临床病理特征中,浸润性癌伴导管原位癌成分(F=21.475,P=0.000),HER2阳性表达(F=5.663,P=0.017)是保乳术中切缘阳性的预测因素。多因素回归分析结果显示,对浸润性乳腺癌保乳术中切缘阳性预测最有价值的MRI特征是多中心病灶(OR=4.381,P<0.001)和较大的病灶最长径(OR=1.796,P=0.019),病理特征是浸润性乳腺癌伴导管原位癌成分(OR=4.211,P<0.001),回归模型对DCIS-IC预测诊断的ROC曲线下面积为0.75。结论:浸润性乳腺癌部分术前MRI特征和病理特征可以帮助临床医生对保乳术中切缘阳性情况进行预测。 Objective:To study the value of preoperative MRI features of breast cancer in predicting positive margins during breast-conserving surgery(BCS).Methods:A total of 176 patients with invasive breast cancer were retrospectively enrolled from Sep 2017 to July 2019 and divided into positive margins group(56 cases) and negative margins group(120 cases).Preoperative MRI features including fibro-glandular tissue(FGT) type, bilateral background parenchymal enhancement(BPE),the type, shape and margin of mass, the distribution of none mass-like enhancement(NMLE),maximum long diameter of lesion, whether or not with multi-centric lesion were analyzed.The basic clinical and pathological information were also collected.The differences between the two groups among the collected features were compared by univariate analysis.The statistical features in univariate analysis were further analyzed by multivariate logistic-regression model.ROC analyses were applied to determine the performance of the model.Results:The positive margins rate was 31.38%(56/176) in this study.In univariate analysis, several MRI features including largest long diameter of tumor(t=3.162,P=0.002),multi-centric lesion(F=17.853,P=0.000),NMLE type(F=11.019,P=0.001) and the clinical-pathology features, including invasive cancer with intra-ductal carcinoma in situ(DCIS) component, HER2 positive, were the predictors of the positive margins during BCS.The logistic regression analysis showed that the invasive cancer with multi-centric lesion(OR=4.381,P=0.000),larger long diameter(OR=1.796,P=0.019) and DCIS component(OR=4.211,P=0.000) and were prone to have positive margins in BCS,and the AUC of the model was 0.750.Conclusion:Several preoperative MRI features and pathological features of invasive breast cancer could help clinicians to predict the positive margins in BCS.
作者 罗红兵 王春华 刘圆圆 陈哲 胥豪 周鹏 任静 LUO Hong-bing;WANG Chun-hua;LIU Yuan-yuan(Department of Radiology,Sichuan Cancer Hospital&Institute,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China)
出处 《放射学实践》 CSCD 北大核心 2022年第3期318-324,共7页 Radiologic Practice
关键词 乳腺肿瘤 磁共振成像 保乳术 切缘阳性 Breast neoplasms Magnetic resonance imaging Breast-conserving surgery Positive margins
  • 相关文献

参考文献7

  • 1H.Agakishiev,M.M.Aggarwal,Z.Ahammed,A.V.Alakhverdyants,I.Alekseev,J.Alford,B.D.Anderson,C.D.Anson,D.Arkhipkin,G.S.Averichev,J.Balewski,D.R.Beavis,N.K.Behera,R.Bellwied,M.J.Betancourt,R.R.Betts,A.Bhasin,A.K.Bhat,H.Bichsel,J.Bieleik,J.Bielcikova,B.Biritz,L.C.Bland,W.Borowski,J.Bouchet,E.Braidot,A.V.Brandin,A.Bridgeman,S.G.Brovko,E.Bruna,S.Bueltmann,I.Bunzarov,T.P.Burton,X.Z.Cai,H.Caines,M.Calderon de la Barca Sanchez,D.Cebra,R.Cendejas,M.C.Cervantes,Z.Chajecki,P.Chaloupka,S.Chattopadhyay,H.F.Chen,J.H.Chen,J.Y.Chen,L.Chen,J.Cheng,M.Cherney,A.Chikanian,K.E.Choi,W.Christie,P.Chung,M.J.M.Codrington,R.Corliss,J.G.Cramer,H.J.Crawford,S.Dash,A.Davila Leyva,L.C.De Silvat,R.R.Debbe,T.G.Dedovich,A.A.Derevschikov,R.Derradi de Souza,L.Didenko,P.Djawotho,S.M.Dogra,X.Dong,J.L.Drachenberg,J.E.Draper,J.C.Dunlop,L.G Efimov,M.Elnim,J.Engelage,G Eppley,M.Estienne,L.Eun,O.Evdokimov,R.Fatemi,J.Fedorisin,A.Feng,R.G.Fersch,P.Filip,E.Finch,V.Fine,Y.Fisyak,C.A.Gagliardi,D.R.Gangadharan,A.Geromitsos,F.Geurts,P.Ghosh,Y.N.Gorbunov,A.Gordon,O.Grebenyuk,D.Grosnick,S.M.Guertin,A.Gupta,W.Guryn,B.Haag,O.Hajkova,A.Hamed,L-X.Han,J.W.Harris,J.P.Hays-Wehle,M.Heinz,S.Heppelmann,A.Hirsch,E.Hjort,G.W.Hoffmann,D.J.Hofiman,B.Huang,H.Z.Huang,T.J.Humanic,L.Huo,G.Igo,P.Jacobs,W.W.Jacobs,C.Jena,F.Jin,J.Joseph,E.G.Judd,S.Kabana,K.Kang,J.Kapitan,K.Kauder,H.Ke,D.Keane,A.Kechechyan,D.Kettler,D.P.Kikola,J.Kiryluk,A.Kisiel,V.Kizka,A.G.Knospe,D.D.Koetke,T.Kollegger,J.Konzer,I.Koralt,L.Koroleva,W.Korsch,L.Kotchenda,V.Kouchpil,P.Kravtsov,K.Krueger,M.Krus,L.Kumar,P.Kurnadi,M.A.C.Lamont,J.M.Landgraf,S.LaPointe,J.Lauret,A.Lebedev,R.Lednicky,J.H.Lee,W.Leight,M.J.LeVine,C.Lil,L.Li,N.Li,W.Li,X.Li,X.Li,Y.Li,Z.M.Li,M.A.Lisa,F.Liu,H.Liu,J.Liu,T.Ljubicic,W.J.Llope,R.S.Longacre,W.A.Love,Y.Lu,E.V.Lukashov,X.Luo,G.L.Ma,Y.G.Mai,D.P.Mahapatra,R.Majka,O.I.Mall,L.K.Mangotra,R.Manweiler,S.Margetis,C.Markert,H.Masui,H.S.Matis,Yu.A.Matulenko,D.MeDonald,T.S.McShane,A.Meschanin,R.Milner,N.G.Minaev,S.Mioduszewski,A.Mischke,M.K.Mitrovski,B.Mohanty,M.M.Mondal,B.Morozov,D.A.Morozov,M.G.Munhoz,M.Naglis,B.K.Nandi,T.K.Nayak,P.K.Netrakanti,L.V.Nogach,S.B.Nurushev,G.Odyniec,A.Ogawa,Oh,Ohlson,V.Okorokov,E.W.Oldag,D.Olsont,M.Pachr,B.S.Page,S.K.Pal,Y.Pandit,Y.Panebratsev,T.Pawlak,H.Pei,T.Peitzmann,C.Perkins,W.Peryt,S.C.Phatak,P.Pile,M.Planinic,M.A.Ploskon,J.Pluta,D.Plyku,N.Poljak,A.M.Poskanzer,B.V.K.S.Potukuchi,C.B.Powell,D.Prindle,N.K.Pruthi,A.M.Poskanzer,B.V.K.S.Potukuchi,B.Powell,D.Prindle,N.K.Pruthi,P.R.Pujahar,J.Putschke,H.Qiu,R.Raniwala,S.Raniwala,R.L.Ray,R.Redwine,R.Reed,H.G.Riter,J.B.Roberts,O.V.Rogachevskiy,J.L.Romero,A.Rose,L.Ruan,J.Rusnak,N.R.Sahoo,S.Sakai,I.Sakrejda,T.Sakuma,S.Salur,J.Sandweiss,E.Sangaline,A.Sarkar,J.Schambach,R.P.Scharenberg,A.M.Schmah,N.Schmitz,T.R.Schuster,J.Seele,J.Seger,I.Selyuzhenkov,P.Seyboth,E.Shahaliev,M.Shao,M.Sharma,S.S.Shi,Q.Y.Shou,E.P.Sichtermann,F.Simon,R.N.Singaraju,M.J.Skoby,N.Smirnov,H.M.Spinka,B.Srivastava,T.D.S.Stanislaus,D.Staszak,S.G.Steadman,J.R.Stevens,R.Stock,M.Strikhanov,B.Stringfellow,A.A.P.Suaide,M.C.Suarez,N.L.Subba,M.Sumbera,X.M.Sun,Y.Sun,Z.Sun,B.Surrow,D.N.Svirida,T.J.M.Symons,A.Szanto de Toledo,J.Takahashi,A.H.Tang,Z.Tang,L.H.Tarini,T.Tarnowsky,D.Thein,J.H.Thomas,J.Tian,A.R.Timmins,D.Tlusty,M.Tokarev,V.N.Tram,S.Trentalange,R.E.Tribble,Tribedy,O.D.Tsai,T.Ullrich,D.G.Underwood,G.Van Buren,G.van Nieuwenhuizen,J.A.Vanfossen,R.Varma,G.M.S.Vasconcelos,A.N.Vasiliev,F.Videbaek,Y.P.Viyogi,S.Vokal,M.Wadat,M.Walker,F.Wang,G.Wang,H.Wang,J.S.Wang,Q.Wang,X.L.Wang,Y.Wang,G.Webb,J.C.Webb,G.D.Westfall,C.Whitten,H.Wieman,S.W.Wissink,R.Witt,W.Witzke,Y.F.Wu,Xiao,W.Xie,H.Xu,N.Xu,Q.H.Xu,W.Xu,Y.Xu,Z.Xu,L.Xue,Y.Yang,P.Yepes,K.Yip,I-K.Yoo,M.Zawisza,H.Zbroszczyk,W.Zhan,J.B.Zhang,S.Zhang,W.M.Zhang,X.P.Zhang,Y.Zhang,Z.P.Zhang,J.Zhao,C.Zhong,W.Zhou,X.Zhu,Y.H.Zhu,R.Zoulkarneev,Y.Zoulkarneeva.Measurements of dihadron correlations relative to the event plane in Au+Au collisions at√^(S)NN=200 GeV[J].Chinese Physics C,2021,45(4):198-241. 被引量:351
  • 2无.保留乳房治疗专家共识(2020年版)[J].中国癌症杂志,2020,30(11):912-967. 被引量:30
  • 3何翠菊,罗娅红,无.乳腺磁共振检查及诊断规范专家共识[J].肿瘤影像学,2017,26(4):241-249. 被引量:21
  • 4李相生,宋云龙,李德昌,祝红线,孟利民,黄蓉蓉,王石林,王东,方红,樊红霞.术前MRI动态增强扫描可降低早期非肿块型乳腺癌保乳术切缘阳性率[J].中华肿瘤杂志,2017,39(10):768-774. 被引量:24
  • 5王文静,洪庆山,张嫣,郭庆禄.磁共振成像在乳腺癌保乳术前评价中的应用[J].实用放射学杂志,2014,30(6):943-946. 被引量:7
  • 6杨阳,康骅,赵菁,凌煜玮,赵烨,王亚军,戎冬冬.术前乳腺MRI对乳腺癌保乳手术切缘评估的回顾性分析[J].首都医科大学学报,2020,41(6):943-953. 被引量:22
  • 7杨真露,李嫣,詹晨奥,胡益祺,霍敏,陈成洋,唐彩丽,覃艳金,艾涛,夏黎明.RSNA2020乳腺影像学[J].放射学实践,2021,36(3):307-310. 被引量:5

二级参考文献27

  • 1万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1305
  • 2Duygulu G,Oktay A,Bilgen I G,et al. The role of breast MRI in planning the surgical treatment of breast cancer[J]. Diagn Interv Radiol,2012,18(5) :460-467.
  • 3Taneja S,Jena A, Zaidi S M, et al. MRI evaluation of the contra- lateral breast in patients .with recently diagnosed breast cancer [J]. Indian J Radiol Imaging, 2012,22 (1) : 69- 73.
  • 4Jatoi I,Benson J R. The ease against routine preoperative breast MRI[J]. Future Oneol, 2013, (3) : 347- 353.
  • 5Cocquyt V F,Blondeel P N, Depypere H T, et al. Better cosmetic results and comparable quality of life after skin-sparing masteeto- my and immediate autologous breast reconstruction compared to breast conservative treatment[J]. Br J Plast Surg, 2003,56 (5): 462-470.
  • 6Fatouros M, Roukos D H, Arampatzis I, et al. Factors increasing local recurrence in breast-conserving surgery[J]. Expert Rev An- ticancer Ther,2005,5(4) :737-745.
  • 7Kunos C, Latson L,Overmoyer B,et al. Breast conservation sur- gery achieving> or = 2 mm tumor-free margins results in de-creased localregiona] recurrence rates [J]. Breast, 2006, 12 ( l ) : 28-36.
  • 8Shin H C,Han W,Moon H G,et al. Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery[J]. Ann Surg Oncol,2012,19(8) :2572-2579.
  • 9Obdeijn I M, Tilanus-Linthorst M M, Spronk S, et al. Preopera- tive breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conser- ving surgery[J]. Am J Roentgenol, 2013,200 (2) : 304 - 310.
  • 10Kropcho L C, Steen S T, Chung A P, et al. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ[J]. Breast J, 2012,18(2) : 151 - 156.

共引文献447

同被引文献49

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部